Modern treatment strategy of ischemic heart disease patients: conservative and surgical technologies ratio



Cite item

Full Text

Abstract

Coronary heart disease (CHD) is the major socially significant disease which has leading positions in the structure of mortality. Modern conservative therapy of CHD is highly efficient, but a number of clinical situations require surgical myocardial revascularization. Invasive technologies allow to perform invasive revascularization both in patients with acute and stable CHD. Precise definition of indications for surgery, choice of type of intervention, evaluation of prognosis, prevention of intraoperative and postoperative complications, rehabilitation and training programs, as well as optimal drug therapy and ambulatory observation can achieve the best short- and long-term results of treatment. Key words: cardiology, coronary heart disease, myocardial revascularization.

Full Text

Restricted Access

About the authors

E V Shlyakhto

Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg

Email: shlyakhto@indox.ru

M A Karpenko

Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg

M L Gordeev

Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg

D A Zverev

Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg

A N Yakovlev

Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg

A V Panov

Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg

E M Nifontov

Almazov Federal Heart, Blood and Endocrinology Centre, St. Petersburg

References

  1. Mackay J., Mensah G. Atlas of Heart Disease and Stroke // World Health Organization. 2004. 112 p.
  2. Conroy R.M., Pyorala K., Fitzgerald A.P. et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project // Eur. Heart. J. 2003. Vol. 24. P. 987-1003.
  3. Graham I., Atar D., Borch-Johnsen K. et al. European guidelines on cardiovascular disease prevention in clinical practice // Eur. J. Cardiovasc. Prev. Reha- bil. 2007. № 14 (Suppl. 2). P. S1-S113.
  4. Messerli F.H., Mancia G., Conti C.R., Pepine C.J. Guidelines on the management of stable angina pectoris // Eur. Heart. J. 2006. Vol. 27. № 23. P. 2902- 2903.
  5. Eagle K.A., Guyton R.A., Davidoff R. et al. АСС/ AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery // Circulation. 2004. Vol. 110. P. 1168-1176.
  6. Patel M.R., Dehmer G.J., Hirshfeld J.W. et al. Appropriateness Criteria for Coronary Revascularization // J. Am. Coll. Cardiol. 2009. Vol. 53. P. 530- • 553.
  7. Shah S.J., Waters D.D., Barter P. Intensive lipidlowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery // J. Am. Coil. Cardiol. 2008. Vol. 51. P. 1938- 1943.
  8. Mandelzweig L., Battler A., Boyko V. et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and Mediterranean Basin in 2004 // Eur. Heart. J. 2006. Vol. 27. P. 2285- 2293.
  9. http://www.pcronline.com/Lectures/2009/EuroP- CR
  10. Mitchell L.B., Exner D.V., Wyse D.G. et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair (PAPABEAR): a randomized controlled trial // JAMA. 2005. Vol. 294. № 24. P.3093-3100.
  11. Панов А.В., Гордеев М.Л., Корженевская К.В. Применение Омакора для предупреждения фибрилляции предсердий после хирургической реваскуляризации миокарда. (Исследование АКСИОМА) // Артериальная гипертензия. 2008. №2. С. 162-164.
  12. Rao S.V., Shaw R.E., Brindis R.G. et al. Patterns and outcomes of drug-eluting coronary stent use in clinical practice // Am. Heart. J. 2006. ѴЫ. 152. № 2. P. 321-326.
  13. Boden W.E., O’Rourke R.A., Тео K. et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease // N. Engl. J. Med. 2007. Vol. 356. P. 1503-1516.
  14. Wijeysundera H.C., Nallamothu B.K., Krumholz H. M. et al. Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief //Ann. Intern. Med. 2010. Vol. 152. P. 370-379.
  15. Schomig A., Mehilli J., de Waha A. et al. A Metaanalysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease // J. Am. Coll. Cardiol. 2008. Vol. 52. P. 894-904.
  16. Hoffman S.N., TenBrook J.A., Wolf M.P. et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: One- to eight-year outcomes // J. Am. Coll. Cardiol. 2003. Vol. 41. P. 1293-1304.
  17. The BARI Investigators: Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status // J. Am. Coll. Cardiol. 2000. Vol. 35. P. 1122-1129.
  18. Porto I., Selvanayagam J.B., Van Gaal W.J. et al. Plaque volume and occurrence and location of peri- procedural myocardial necrosis after percutaneous coronary intervention // Circulation. 2006. ѴЫ. 114. P. 662-669.
  19. Bahrmann P., Werner G.S., Heusch G. et al. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions//Circulation. 2007. Vol. 115. P. 600-608.
  20. Burzotta F., Testa L., Giannico F. Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trials // Int. J. Cardiol. 2008. Vol. 123. P. 313-321.
  21. Eastaugh J.L., Calvert M.J., Freemantle N. Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients // Family Practice. 2005. Vol. 22. P. 43-50.
  22. Taylor R.S., Brown A., Ebrahim S. et al. Exercise- based rehabilitation for patients with coronary heart disease: systematic review // Am. J. Med. 2004. Vol. 116. P.682-697.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Shlyakhto E.V., Karpenko M.A., Gordeev M.L., Zverev D.A., Yakovlev A.N., Panov A.V., Nifontov E.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies